T1	Treatment 23 34	sitaxsentan
T2	Treatment 141 155	of sitaxsentan
T3	Treatment 227 249	BACKGROUND Sitaxsentan
T4	Treatment 413 431	Before sitaxsentan
T5	Treatment 528 558	receive placebo or sitaxsentan
T6	Treatment 848 863	for sitaxsentan
T7	Treatment 872 886	versus placebo
T8	Treatment 1023 1039	with sitaxsentan
T9	Treatment 1062 1076	strong placebo
T10	Treatment 1175 1217	receiving sitaxsentan 100Â mg than placebo
T11	Treatment 1324 1360	for 100-mg sitaxsentan patients than
T12	Treatment 1420 1447	frequently with sitaxsentan
T13	Treatment 1593 1615	CONCLUSION Sitaxsentan
T14	Treatment 1735 1752	patient receiving
T15	Treatment 1785 1804	clinical worsening;
